Lardot C, Broeckaert F, Lison D, Buchet J P, Lauwerys R
Industrial Toxicity and Occupational Medicine Unit, School of Medicine, Catholic University of Louvain, Brussels, Belgium.
J Toxicol Environ Health. 1996 Apr 19;47(6):509-22. doi: 10.1080/009841096161500.
Enhancement of lung antioxidant capacity has been proposed in the therapy of acute lung injuries involving local accumulation of reactive oxygen species (ROS). We have studied in the female Sprague-Dawley rat the effect of intratracheal administration of catalase (CAT) on the acute lung response induced by different ROS generating systems. The lung response was assessed at several time intervals (60-360 min) by monitoring in bronchoalveolar fluid (BALF) the activity of lactate dehydrogenase and the levels of total protein, albumin, and glucose. While CAT (50,000 IU/rat) significantly reduced the biochemical changes induced by hydrogen peroxide produced by a glucose/glucose oxidase system, it markedly exacerbated the lesions induced by phorbol myristate acetate (PMA). Several observations indicate that a particular chemical species formed during the catalase inactivation process is responsible for this effect. Parallel to the development of the lung damage, we noted a rapid reduction of CAT activity (80%) in the BALF of animals treated with PMA and CAT. In vitro an inhibition of CAT activity was observed in the presence of a superoxide anion generating system, and this inhibition was prevented by superoxide dismutase (SOD). A dose of 10,000 IU superoxide dismutase did not prevent the development of the lung lesions induced by PMA plus CAT. Administered alone or in association with PMA, CAT inactivated by heat or 3-aminotriazole also caused severe lung damage. In conclusion, the present study indicates that exogenous catalase may not always protect against the inflammatory reaction resulting from an oxidative stress. In the presence of superoxide anions, catalase may aggravate the lesions, and this possibility should be kept in mind when considering an antioxidant therapy.
在涉及活性氧(ROS)局部积累的急性肺损伤治疗中,已提出增强肺抗氧化能力的方法。我们在雌性Sprague-Dawley大鼠中研究了气管内给予过氧化氢酶(CAT)对不同ROS生成系统诱导的急性肺反应的影响。通过监测支气管肺泡灌洗液(BALF)中乳酸脱氢酶的活性以及总蛋白、白蛋白和葡萄糖的水平,在几个时间间隔(60 - 360分钟)评估肺反应。虽然CAT(50,000 IU/大鼠)显著降低了葡萄糖/葡萄糖氧化酶系统产生的过氧化氢诱导的生化变化,但它明显加剧了佛波酯肉豆蔻酸酯(PMA)诱导的损伤。几项观察结果表明,在过氧化氢酶失活过程中形成的一种特定化学物质是造成这种效应的原因。与肺损伤的发展同时,我们注意到用PMA和CAT处理的动物的BALF中CAT活性迅速降低(80%)。在体外,在存在超氧阴离子生成系统的情况下观察到CAT活性受到抑制,并且这种抑制被超氧化物歧化酶(SOD)阻止。10,000 IU超氧化物歧化酶的剂量并不能阻止PMA加CAT诱导的肺损伤的发展。单独给予或与PMA联合给予时,经热或3 - 氨基三唑失活的CAT也会导致严重的肺损伤。总之,本研究表明外源性过氧化氢酶可能并不总是能预防氧化应激引起的炎症反应。在存在超氧阴离子的情况下,过氧化氢酶可能会加重损伤,在考虑抗氧化治疗时应牢记这种可能性。